Dj. Pinsky et al., QT DISPERSION AS A MARKER OF RISK IN PATIENTS AWAITING HEART-TRANSPLANTATION, Journal of the American College of Cardiology, 29(7), 1997, pp. 1576-1584
Objectives. The objectives of this study were to determine whether a s
ignal-averaged electrocardiogram (SAECG) or measurement of interlead v
ariability of QT intervals on an electrocardiogram (ECG) obtained at t
he time of wait-listing could provide prognostic value with respect to
cardiac death during the waiting period. Background. Because heart tr
ansplantation is a life-saving but limited resource, there remains an
urgent need to identify those patients at greatest risk of dying while
awaiting heart transplantation as part of the strategy to optimize th
e allocation of donor organs to those in greatest need, This study was
undertaken to prospectively identify clinical, ECG or SAECG variables
that might predict mortality during the waiting period. Methods. Of 1
08 consecutive patients referred for heart trans plant evaluation, 80
were placed on a waiting list, at which time a standard 12-lead ECG an
d a SAECG were recorded. In this cohort of 80 patients, QT dispersion
was characterized from the 12-lead ECG as either the maximal-minimal Q
T interval (QTDISP) or as the coefficient of variation of all QT inter
vals (QTCV). Results. During the 25-month follow-up period (mean time
on waiting list, 201 days), the mortality rate was 27%/year, divided e
qually between heart failure and sudden deaths, No clinical variable i
dentified at entry predicted mortality, QTDISP and QTCV were strong mo
rtality predictors, with a 4.1-fold increase in mortality in patients
with QTDISP > 140 ms compared with those patients with QTDISP less tha
n or equal to 140 ms (95% CI 1.1 to 14.9), whereas a QTCV greater than
or equal to 9% also predicted a 4.1-fold increased risk of death (95%
CI 1.4 to 11.8). Although 88% of all SAECGs were abnormal, no patient
with a normal SAECG died suddenly during the waiting period. Conclusi
ons. Indexes of QT dispersion provide a means of stratifying a patient
's risk of dying while awaiting heart transplantation and may help to
establish priority on a heart transplant waiting list. (C) 1997 by the
American College of Cardiology.